Daewon Pharmaceutical Co., Ltd. (KRX:003220)
13,740
-100 (-0.72%)
At close: Mar 28, 2025, 3:30 PM KST
Daewon Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 14,210 | 23,917 | 31,944 | 6,989 | 17,640 | Upgrade
|
Depreciation & Amortization | 20,095 | 17,561 | 19,368 | 17,805 | 15,674 | Upgrade
|
Loss (Gain) From Sale of Assets | -25.42 | -149.95 | -45.71 | 0.86 | -2.34 | Upgrade
|
Asset Writedown & Restructuring Costs | 4,671 | 4,597 | 2,154 | 1,111 | 715.77 | Upgrade
|
Loss (Gain) From Sale of Investments | 1,149 | 61.5 | 752.76 | 870.39 | -1,990 | Upgrade
|
Loss (Gain) on Equity Investments | -704.2 | -509.42 | -860.08 | -382.62 | -517.27 | Upgrade
|
Provision & Write-off of Bad Debts | -204.13 | 230.88 | 887.59 | -250.26 | -171.71 | Upgrade
|
Other Operating Activities | 17,840 | 10,638 | 13,240 | 13,054 | 7,952 | Upgrade
|
Change in Accounts Receivable | -2,504 | -7,949 | -11,075 | -11,278 | 3,819 | Upgrade
|
Change in Inventory | -6,642 | -15,837 | -23,989 | -4,075 | -13,944 | Upgrade
|
Change in Accounts Payable | 1,041 | 938.61 | 2,107 | -1,445 | 1,559 | Upgrade
|
Change in Income Taxes | 3.21 | -2.03 | 5.05 | -0.32 | 0.49 | Upgrade
|
Change in Other Net Operating Assets | -18,894 | 18,239 | -8,075 | 14.07 | -5,784 | Upgrade
|
Operating Cash Flow | 30,035 | 51,734 | 26,413 | 22,413 | 24,951 | Upgrade
|
Operating Cash Flow Growth | -41.94% | 95.86% | 17.85% | -10.17% | -19.43% | Upgrade
|
Capital Expenditures | -34,864 | -12,289 | -8,009 | -4,104 | -11,346 | Upgrade
|
Sale of Property, Plant & Equipment | 778.66 | 204.25 | 504.44 | 5.16 | 42.79 | Upgrade
|
Cash Acquisitions | -7.62 | - | - | -14,602 | - | Upgrade
|
Sale (Purchase) of Intangibles | -18,218 | -8,322 | -5,357 | -7,603 | -4,038 | Upgrade
|
Investment in Securities | -12,380 | -893.53 | -9,055 | -16,256 | -33.31 | Upgrade
|
Other Investing Activities | 21,020 | -47,331 | 1,520 | 562.08 | 556.22 | Upgrade
|
Investing Cash Flow | -42,975 | -68,267 | -20,775 | -41,615 | -14,893 | Upgrade
|
Short-Term Debt Issued | 60,421 | 20,081 | 300 | 27,069 | - | Upgrade
|
Long-Term Debt Issued | 42,000 | 22,000 | 3,352 | 45,920 | - | Upgrade
|
Total Debt Issued | 102,421 | 42,081 | 3,652 | 72,989 | - | Upgrade
|
Short-Term Debt Repaid | -45,000 | -234.39 | -468.76 | -10,063 | - | Upgrade
|
Long-Term Debt Repaid | -42,958 | -10,666 | -10,062 | -9,479 | -1,228 | Upgrade
|
Total Debt Repaid | -87,958 | -10,900 | -10,530 | -19,541 | -1,228 | Upgrade
|
Net Debt Issued (Repaid) | 14,463 | 31,181 | -6,878 | 53,448 | -1,228 | Upgrade
|
Issuance of Common Stock | - | 106.64 | - | 210.31 | - | Upgrade
|
Repurchase of Common Stock | - | - | -6,171 | -85.84 | -5,062 | Upgrade
|
Dividends Paid | -6,359 | -7,340 | -4,120 | -3,140 | -5,035 | Upgrade
|
Other Financing Activities | -8,402 | -4,434 | -3,241 | -1,906 | -1,260 | Upgrade
|
Financing Cash Flow | -297.81 | 19,513 | -20,411 | 48,527 | -12,584 | Upgrade
|
Foreign Exchange Rate Adjustments | 312.22 | 32.09 | 45.26 | 40.01 | -39.13 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | 1,893 | - | Upgrade
|
Net Cash Flow | -12,926 | 3,013 | -14,727 | 31,258 | -2,565 | Upgrade
|
Free Cash Flow | -4,829 | 39,446 | 18,405 | 18,309 | 13,605 | Upgrade
|
Free Cash Flow Growth | - | 114.32% | 0.52% | 34.58% | - | Upgrade
|
Free Cash Flow Margin | -0.81% | 7.49% | 3.84% | 5.17% | 4.41% | Upgrade
|
Free Cash Flow Per Share | -249.80 | 1880.17 | 841.34 | 862.87 | 637.47 | Upgrade
|
Cash Interest Paid | 6,513 | 4,421 | 3,230 | 1,858 | 1,255 | Upgrade
|
Cash Income Tax Paid | 4,821 | 5,211 | 7,522 | 8,922 | 10,086 | Upgrade
|
Levered Free Cash Flow | -28,202 | 2,590 | 10,196 | 14,843 | 3,209 | Upgrade
|
Unlevered Free Cash Flow | -22,386 | 5,474 | 12,498 | 16,142 | 3,948 | Upgrade
|
Change in Net Working Capital | 6,071 | 11,622 | 20,319 | 2,022 | 11,328 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.